sellWeak
Lionel F. Conacher sold $1,086 of SRXH
director at Better Choice Co Inc.. 635 shares at an average of $1.71, traded Dec 23, 2024, filed Dec 26, 2024.
Warning score
15Value
$1,086
635 shares
Holdings after
36,597
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$1k at market
- 0Share of holdings soldSold 1.7% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001493152-24-052046, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 23, 2024 | SOpen-market sale Common Stock | -635 | $1.71 | $1,086 | 36,597 | Dec 26, 2024 |
| Nov 20, 2024 | POpen-market purchase Common Stock | +5,000 | $1.71 | $8,550 | 37,232 | Dec 26, 2024 |
| Feb 1, 2024 | POpen-market purchase Common Stock | +8,418 | $11.88 | $100k | 32,232 | Dec 26, 2024 |
| Sep 5, 2023 | POpen-market purchase Common Stock | +17,045 | $6.97 | $119k | 23,814 | Dec 26, 2024 |
| Jun 26, 2024 | POpen-market purchase Stock Options - Right to Buyderivative | +0 | $5.00 | $0 | 5,200 | Dec 26, 2024 |
| Sep 28, 2021 | POpen-market purchase Stock Options - Right to Buyderivative | +0 | $159.28 | $0 | 615 | Dec 26, 2024 |
Related signals
Other insiders at Better Choice Co Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | Better Choice Co Inc. | Lionel F. Conacher director | $227k 30,463 shares | +450% | |
| 26Weak | Better Choice Co Inc. | Michael Young director | $2,578 20,000 shares | +20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.